View today's stock price, news and analysis for Acasti Pharma Inc. (ACST). Barron's also provides information on historical stock ratings, target prices, company 1 Oct 2019 Acasti Pharma Inc (NASDAQ:ACST) (CVE:ACST) CSO & COO Pierre Lemieux tells Proactive the Québec-based company is 'marching to the 21 Feb 2019 Acasti Pharma Inc. (TSXV: ACST) is one of this year's TSX Venture 50 capitalization growth, share price appreciation and trading volume. Historical daily share price chart and data for Acasti Pharma since 2020 adjusted for splits. The latest closing stock price for Acasti Pharma as of April 03, 2020 is
Acasti Pharma Inc., ACST Quick Chart - (NAS) ACST, Acasti ...
ACST Acasti Pharma, Inc. Class A Common Stock - NASDAQ.com Acasti Pharma, Inc. Class A Common Stock (ACST) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Acasti Pharma, Inc. Class A Common Stock (ACST) Analyst ... Mar 20, 2020 · Acasti Pharma, Inc. Class A Common Stock (ACST) Analyst Research. ACST Analyst Ratings. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. ACST - Acasti Pharma Inc Stock quote - CNNMoney.com Find real-time ACST - Acasti Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. ACST - Acasti Pharma Inc Stock quote - CNNMoney.com Markets
Stock analysis for Acasti Pharma Inc (ACST:Venture) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Get today's Acasti Pharma Inc stock price and latest ACST news as well as Acasti Pharma real-time stock quotes, technical analysis, full financials and more. 12 Feb 2020 a Buy rating on Acasti Pharma (ACST), with a price target of $7.00. Gershell covers the Healthcare sector, focusing on stocks such as Stockopedia rates Acasti Pharma Inc as a Speculative Style Neutral . 2 brokers rate it 12m Forecast Rolling, Industry, Market ACST Share Price Performance . 18 Jul 2019 Oppenheimer Starts Acasti Pharma (ACST) at Outperform Get instant alerts when news breaks on your stocks. initiates coverage on Acasti Pharma ( NASDAQ: ACST) with a Outperform rating and a price target of $7.00. 26 Dec 2019 Oppenheimer analyst Leland Gershell reiterated an Outperform rating and $7.00 price target on Acasti Pharma (NASDAQ: ACST). The analyst 26 Mar 2020 The company in its last quarterly report recorded -$0.14 earnings per share which is below the predicted by most analysts. The Acasti Pharma
Company News and Releases - Acasti Pharma Inc., ACST (NAS ...
Delays at Acasti Pharma (Acasti Pharma Stock Quote, Chart, News TSXV:ACST) have Echelon Wealth Partners analyst Douglas Loe lowering his price …
Acasti Pharma stock price target cut to $2 from $8 at B. Riley FBR MarketWatch. Monday, January 13, 2020. 02:32 PM ET. Amarin's stock surges, as rival drugs from AstraZeneca, Acasti disappoint MarketWatch. Thursday, July 18, 2019. 07:21 AM ET. Acasti Pharma started at outperform with $7 stock price target at Oppenheimer MarketWatch. More
Acasti Pharma Inc (ACST-X) Quote - The Globe and Mail Detailed price information for Acasti Pharma Inc (ACST-X) from The Globe and Mail including charting and trades. Detailed price information for Acasti … Acasti Pharma Inc : ACST Stock Price Quote at Ally Invest Analyst Actions: HC Wainwright Halves Acasti Pharma's Price Target to $3 From $6, Reiterates Buy Rating 11:05AM ET 2/18/2020 MT Newswires. Acasti Pharma (ACST) has an average analyst rating of buy, with an average price target of $5. ACST Stock Price and Chart — NASDAQ:ACST — TradingView
Stock analysis for Acasti Pharma Inc (ACST:Venture) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Acasti Pharma has price target cut at Echelon - Cantech Letter Delays at Acasti Pharma (Acasti Pharma Stock Quote, Chart, News TSXV:ACST) have Echelon Wealth Partners analyst Douglas Loe lowering his price … ACST Stock Price & Charts | Acasti Pharma In depth view into ACST (Acasti Pharma) stock including the latest price, news, dividend history, earnings information and financials.